• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    aTyr Pharma, Inc. - Common Stock (NQ:ATYR)

    0.1722 -0.0011 (-0.63%)
    Delayed Quote Updated: 3:53 PM EDT, Oct 21, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about aTyr Pharma, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    Discover the most active stocks in Thursday's session. ↗
    Via Chartmill
    News headline image
    Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
    Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    Stay updated with the stocks that are on the move in today's after-hours session. ↗
    Via Chartmill
    What's going on in today's session ↗
    Via Chartmill
    Which stocks are moving on Tuesday? ↗
    Via Chartmill
    News headline image
    aTyr Pharma Revamps Efzofitimod Path With New Phase III Sarcoidosis Trial ↗
    aTyr Pharma (NASDAQ:ATYR) said it plans to conduct a new Phase III trial of efzofitimod in pulmonary sarcoidosis after receiving feedback from the U.S. Food and Drug Administration at a recent Type C... 
    Via MarketBeat
    Top movers in Thursday's session ↗
    Via Chartmill
    Thursday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
    From Faruqi & Faruqi, LLP
    Via Business Wire
    News headline image
    ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds aTyr Investors to Contact the Firm Before December 8th Regarding Their Rights
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Deadline Soon: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Which stocks are moving after the closing bell on Tuesday? ↗
    Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
    Via Chartmill
    News headline image
    Bragar Eagel & Squire, P.C. Urgently Reminds Stockholders of Molina, aTyr, and Marex to Contact the Firm Before Upcoming Deadlines
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Shareholders of aTyr Pharma, Inc. Should Contact Levi & Korsinsky Before December 8, 2025 to Discuss Your Rights - ATYR
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    Shareholders of aTyr Pharma, Inc. Should Contact Levi &amp; Korsinsky Before December 8, 2025 to Discuss Your Rights - ATYR
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    Bragar Eagel & Squire, P.C. Urges Investors of aTyr, Marex, Cepton, and MoonLake to Inquire About Their Rights Before Upcoming Deadlines
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Investors Who Lost Money on aTyr Pharma, Inc. (ATYR) Should Contact Levi &amp; Korsinsky About Pending Class Action - ATYR
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    Investors Who Lost Money on aTyr Pharma, Inc. (ATYR) Should Contact Levi & Korsinsky About Pending Class Action - ATYR
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi &amp; Korsinsky Before December 8, 2025 to Discuss Your Rights - ATYR
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 8, 2025 to Discuss Your Rights - ATYR
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.